OCTOBER 4, 2019
Biophytis Opens 22nd Clinical Site in the SARA-INT Phase 2b Trial of Sarconeos (BIO101) for the Treatment of Sarcopenia. Read the Press Release
OCTOBER 2, 2019
Biophytis to Present Four Posters at the 24th Annual Congress of the World Muscle Society (WMS) in Copenhagen, Denmark. Read the Press Release
SEPTEMBER 26, 2019
Biophytis to Present at the 15th International Congress of the European Geriatric Medicine Society in Krakow, Poland. Read the Press Release
SEPTEMBER 19, 2019
Biophytis to Present at 15th International Pharma Licensing Symposium in Paris. Read the Press Release
AUGUST 23, 2019
Biophytis has signed €24m bond funding from Negma to continue the development of its drug candidates to treat neuromuscular diseases. Read the Press Release
AUGUST 8, 2019
Shareholders Aprove All Resolutions of the Extraordinary General Meeting held on August 8, 2019. Read the Press Release
JULY 25, 2019
Biophytis Withdraws Registration Statement for Global Offering. Read the Press Release
JULY 12, 2019
Biophytis Announces Filing of Amendment to Registration Statement for Global Offering. Read the Press Release
JULY 8, 2019
Biophytis Announces the Launch of its Public Offering on Nasdaq. Read the Press Release
June 28, 2019
Biophytis Announces Results of 2019 Annual General Meeting of Shareholders. Read the Press Release